Cancer usually arises through a number of genetic changes, which result in out-of-control cell growth and cause tumours to grow and spread. The latest medical approach to cancer – often called ‘personalised medicine’ – involves treating patients based on the genetic changes present in their cancer.

This project aims to use genomic sequencing to identify genetic changes that are advancing the growth of a patient’s cancer, and then target these changes with specific drug therapies, where available. The project is a collaborative effort across multiple hospitals and cancer types including melanoma (skin cancer), lung cancer, paediatric (childhood) cancers and rare cancers.

It is anticipated that approximately 30% to 60% of patients might receive a targeted drug therapy as a result of genomic sequencing.

Click here for more information on Melbourne Genomics' advanced solid cancers project.

Subscribe

We could talk genomics all day, but we’ll send you only what’s useful and interesting.

Melbourne Genomics acknowledges the Wurundjeri people of the Kulin Nation, on whose lands we work, and all First Nations peoples across Victoria. We pay respect to Elders past and present. We also acknowledge the First Nations health professionals, researchers and leaders who are shaping the future of genomic medicine.

© 2014–2024 Melbourne Genomics Health Alliance